Literature DB >> 12672254

Structure-activity relationships of (S,Z)-2-aminopurine methylenecyclopropane analogues of nucleosides. Variation of purine-6 substituents and activity against herpesviruses and hepatitis B virus.

Xinchao Chen1, Earl R Kern, John C Drach, Elizabeth Gullen, Yung-Chi Cheng, Jiri Zemlicka.   

Abstract

A series of 13 new (S,Z)-2-aminopurine methylenecyclopropane analogues was synthesized, and their antiviral activity was investigated. The nucleophilic displacement of chlorine of 2-amino-6-chloropurine derivative 5 with allyl-, propargyl-, cyclopropylmethyl-, isopropyl-, benzyl-, cyclohexyl-, and 2-hydroxyethylamine gave N(6)-alkyl compounds 2a, 2b, 2c, 2d, 2e,2f, and 2g. A similar reaction of 5 with allyl, cyclopropylmethyl, propyl, or pentyl alcohol catalyzed by K(2)CO(3) afforded O(6)-alkyl analogues 3a, 3c, 3h and 3i. Propane- and pentanethiol furnished S(6)-alkyl compounds 4h and 4i. The N(6)-alkyl derivatives 2a, 2b, O(6) analogues 3a, 3c, 3h, 3i, and S(6) compounds 4h, 4i which were highly effective in all CMV assays and exhibited the lowest cytotoxicity in proliferating HFF cells appear to be good candidates for in vivo assays. Activity of new analogues against HSV-1 or HSV-2 was restricted to BSC-1 and Vero cultures. Compounds 2c, 2b, 3a and 3h were effective against EBV in one of two assays (Daudi or H-1). Analogues 3a and 4i were the most active anti-VZV agents whereas compounds 3h, 3i, and 4h inhibited the replication of HBV in a micromolar concentration range.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672254     DOI: 10.1021/jm0205245

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  The search for new therapies for human cytomegalovirus infections.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Virus Res       Date:  2010-11-21       Impact factor: 3.303

2.  Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase.

Authors:  Chengwei Li; Brian G Gentry; John C Drach; Jiri Zemlicka
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-09       Impact factor: 1.381

3.  A New Alkylation-Elimination Method for Synthesis of Antiviral Fluoromethylenecyclopropane Analogues of Nucleosides.

Authors:  Shaoman Zhou; Jiri Zemlicka
Journal:  Tetrahedron       Date:  2005-07-25       Impact factor: 2.457

4.  In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.

Authors:  Earl R Kern; Nicole L Kushner; Caroll B Hartline; Stephanie L Williams-Aziz; Emma A Harden; Shaoman Zhou; Jiri Zemlicka; Mark N Prichard
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides.

Authors:  John D Williams; Atiyya R Khan; Emma A Harden; Caroll B Hartline; Geraldine M Jefferson; Kathy A Keith; Mark N Prichard; Jiri Zemlicka; Norton P Peet; Terry L Bowlin
Journal:  Bioorg Med Chem       Date:  2012-05-01       Impact factor: 3.641

6.  Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.

Authors:  Han Chen; Chengwei Li; Jiri Zemlicka; Brian G Gentry; Terry L Bowlin; Donald M Coen
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

7.  Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions.

Authors:  Gloria Komazin-Meredith; Sunwen Chou; Mark N Prichard; Caroll B Hartline; Steven C Cardinale; Katelyn Comeau; John D Williams; Atiyya R Khan; Norton P Peet; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

8.  Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.

Authors:  Mark N Prichard; John D Williams; Gloria Komazin-Meredith; Atiyya R Khan; Nathan B Price; Geraldine M Jefferson; Emma A Harden; Caroll B Hartline; Norton P Peet; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

9.  Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.

Authors:  Brian G Gentry; Jeremy P Kamil; Donald M Coen; Jiri Zemlicka; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

10.  Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin A.

Authors:  Kana M Sureshan; Andrew M Riley; Mark P Thomas; Stephen C Tovey; Colin W Taylor; Barry V L Potter
Journal:  J Med Chem       Date:  2012-02-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.